PPTA Twitter

PlasmaProteins Once #plasma is collected from a donor, it is held in inventory for 60 days as part of the industry’s standards program to ensure the plasma’s safety. Learn more about the importance of plasma for people with serious conditions: bit.ly/2DnAEXf pic.twitter.com/mPP7tAI2Cw
About 18 hours ago.
PlasmaProteins Primary immunodeficiencies (PI) are severe, chronic conditions that prevent immune systems from functioning properly. Each year, more than 130 #plasma donations are needed to treat just one person #LivingWithPI . bit.ly/2QF6N1B pic.twitter.com/FuDxI2jWOU
2 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100